The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fruquintinib combined with FOLFIRI/mFOLFOX6 as second-line treatment in patients with RAS-mutant metastatic colorectal cancer (mCRC): A multicenter, open-label, phase II study.
 
Yun Xu
No Relationships to Disclose
 
Yuchen Wu
No Relationships to Disclose
 
Yuedi Dai
No Relationships to Disclose
 
Xiaopin Ji
No Relationships to Disclose
 
Zhe Cui
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Ye Xu
No Relationships to Disclose